Update shared on 27 Nov 2025
Fair value Decreased 12%Analysts have revised Vitasoy International Holdings' fair value estimate downward from $9.97 to $8.77. This change is based on updated forecasts for higher revenue growth and profit margins, along with a slightly increased discount rate and lower future price-to-earnings expectations.
What's in the News
- The Board of Vitasoy International Holdings Limited will meet on November 25, 2025 to consider approval of interim results for the six months ended September 30, 2025 and discuss a potential interim dividend recommendation (Key Developments).
- On September 2, 2025, Vitasoy International Holdings Limited commenced a share repurchase program. The program authorizes buybacks of up to 10% of issued share capital, aiming to enhance net asset value and earnings per share (Key Developments).
Valuation Changes
- Fair Value Estimate has fallen from HK$9.97 to HK$8.77.
- Discount Rate has risen slightly from 6.77% to 6.90%.
- Revenue Growth forecast has increased from 1.61% to 2.15%.
- Net Profit Margin projection has improved from 4.21% to 5.20%.
- Future P/E Ratio expectation has dropped significantly from 45.89x to 32.65x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.